All blog items

The School of Medicine Office for Faculty is pleased to announce the 2022 Duke Clinical Leadership Program (DCLP) participants.

Geoff Ginsburg, MD, PhD, professor of medicine, pathology, and biostatistics and bioinformatics, and the founding director of MEDx (Medicine + Engineering at Duke), will step down as director in January 2022. In an interview, he reflects on the creation of MEDx and its accomplishments, people, growth, and more.

Children and staff who repeatedly test negative for COVID-19 after contact with someone who has the illness can safely remain in school if universal masking programs are in place, according to a new “test-to-stay” study report from the ABC Science Collaborative.

Mark McClellan, the Robert J. Margolis Professor of Business, Medicine, and Policy, has been reappointed for a second five-year term as Director of the Duke-Margolis Center for Health Policy. McClellan was initially appointed in 2016 to oversee the university-wide, interdisciplinary Margolis Center for Health Policy to further health policy scholarship, research and analysis and to prepare the next generation of health policy leaders.

The newest COVID-19 variant – omicron – casts a larger shadow each day, driving infection rates up just as millions of Americans prepare to travel for the upcoming holidays. Should people get tested first? Should they hug grandma? Will students coming home from college become huge virus vectors?

About 38 million people worldwide are living with AIDS. Pharmaceutical treatments can keep the disease in check, but a vaccine remains elusive despite decades of concerted effort. However, a recent discovery at the Duke Human Vaccine Institute (DHVI) brings the goal of an effective vaccine within reach.

With numerous recent studies demonstrating that antibiotics work as well as surgery for most uncomplicated appendicitis cases, the non-surgical approach can now be considered a routine option, according to a review article in JAMA

A recent shift for NIH-funded T32 graduate training programs, especially those supported by the National Institute for General Medical Sciences (NIGMS), has been to emphasize trainee focused educational objectives. PhD students in T32-funded programs are expected to attain technical (research) operational (skills), and professional (career) competencies that prepare them for entering diverse careers.

The National Institute of Allergy and Infectious Diseases awarded researchers at the Duke Human Vaccine Institute a contract that enables it to compete for projects advancing investigational vaccines to production for use in early clinical trials.

The School of Medicine Office for Faculty is pleased to announce the 2022 LEADER participants.